An unusual placebo effect in Aligos Therapeutics’ Phase IIa trial is driving shareholder skepticism for its metabolic ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Novo Nodrisk’s cannabinoid receptor–targeting obesity pill was picked up in the $1.1 billion acquisition of Inversago ...

The positive readout in patients with non-relapsing secondary progressive multiple sclerosis comes on the heels of ...

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with ...

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...

Job security is a hot topic among biopharma professionals. A career coach offers advice for how to evaluate and build it up ...

SAN DIEGO, Sept. 19, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the TD Cowen 4 th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit at 11:00 a.m.